Search

Jerry B. Dennison

Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )

Most Active Art Unit
2443
Art Unit(s)
2443, 2409, 2143, 2419
Total Applications
1015
Issued Applications
700
Pending Applications
74
Abandoned Applications
250

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17154943 [patent_doc_number] => 20210315994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS [patent_app_type] => utility [patent_app_number] => 17/130812 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73909 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130812 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/130812
DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS Dec 21, 2020 Pending
Array ( [id] => 17141967 [patent_doc_number] => 20210309979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => Enzyme Variants With Improved Ester Synthase Properties [patent_app_type] => utility [patent_app_number] => 17/116817 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39765 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/116817
Enzyme Variants With Improved Ester Synthase Properties Dec 8, 2020 Abandoned
Array ( [id] => 18837717 [patent_doc_number] => 11845780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Mutant lysenin pores [patent_app_type] => utility [patent_app_number] => 17/108536 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28332 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/108536
Mutant lysenin pores Nov 30, 2020 Issued
Array ( [id] => 16686749 [patent_doc_number] => 20210069224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => Compositions and Methods for Topical and Diagnostic and Therapeutic Transport [patent_app_type] => utility [patent_app_number] => 17/100806 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22703 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/100806
Compositions and Methods for Topical and Diagnostic and Therapeutic Transport Nov 19, 2020 Abandoned
Array ( [id] => 19622905 [patent_doc_number] => 12161697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Nanospheres for bone fracture [patent_app_type] => utility [patent_app_number] => 17/094114 [patent_app_country] => US [patent_app_date] => 2020-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 22905 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/094114
Nanospheres for bone fracture Nov 9, 2020 Issued
Array ( [id] => 18058372 [patent_doc_number] => 20220389458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => LOW VOLUME TRANSFECTION [patent_app_type] => utility [patent_app_number] => 17/771333 [patent_app_country] => US [patent_app_date] => 2020-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/771333
LOW VOLUME TRANSFECTION Nov 1, 2020 Abandoned
Array ( [id] => 17198690 [patent_doc_number] => 20210338784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => Botulinum Toxin Pharmaceutical Composition Comprising Tannic Acid [patent_app_type] => utility [patent_app_number] => 17/081853 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081853 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/081853
Botulinum Toxin Pharmaceutical Composition Comprising Tannic Acid Oct 26, 2020 Abandoned
Array ( [id] => 17035013 [patent_doc_number] => 20210251971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases [patent_app_type] => utility [patent_app_number] => 17/079859 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/079859
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases Oct 25, 2020 Pending
Array ( [id] => 17035013 [patent_doc_number] => 20210251971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases [patent_app_type] => utility [patent_app_number] => 17/079859 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13182 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/079859
Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases Oct 25, 2020 Pending
Array ( [id] => 16806230 [patent_doc_number] => 20210128783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => LAMINATED SKIN MIMETIC [patent_app_type] => utility [patent_app_number] => 17/061245 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/061245
LAMINATED SKIN MIMETIC Sep 30, 2020 Abandoned
Array ( [id] => 17769383 [patent_doc_number] => 11401311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-02 [patent_title] => Recombinant activin A precursor protein [patent_app_type] => utility [patent_app_number] => 17/025242 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10722 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025242 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/025242
Recombinant activin A precursor protein Sep 17, 2020 Issued
Array ( [id] => 17897375 [patent_doc_number] => 20220307037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => SYSTEMS AND METHODS FOR PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/761929 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -69 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761929 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761929
SYSTEMS AND METHODS FOR PROTEIN EXPRESSION Sep 14, 2020 Pending
Array ( [id] => 16713322 [patent_doc_number] => 20210080469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => ANOLITER-SCALE SAMPLE PROCESSING AND MASS SPECTROMETRY ACQUISITION METHOD FOR SINGLE CELL PROTEOMICS [patent_app_type] => utility [patent_app_number] => 17/021319 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021319 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021319
ANOLITER-SCALE SAMPLE PROCESSING AND MASS SPECTROMETRY ACQUISITION METHOD FOR SINGLE CELL PROTEOMICS Sep 14, 2020 Pending
Array ( [id] => 16776627 [patent_doc_number] => 20210113704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => NOVEL TOXIN-DERIVED DELIVERY CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 17/015011 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015011 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015011
Toxin-derived delivery constructs for pulmonary delivery Sep 7, 2020 Issued
Array ( [id] => 16776394 [patent_doc_number] => 20210113471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => ANNELID HAEMOGLOBIN LYOPHILISATION PROCESS [patent_app_type] => utility [patent_app_number] => 17/014445 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014445 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014445
Annelid haemoglobin lyophilisation process Sep 7, 2020 Issued
Array ( [id] => 16855221 [patent_doc_number] => 20210155966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS [patent_app_type] => utility [patent_app_number] => 17/014311 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014311 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014311
PRODUCTION OF STEVIOL GLYCOSIDES IN RECOMBINANT HOSTS Sep 7, 2020 Abandoned
Array ( [id] => 16932444 [patent_doc_number] => 20210198333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE [patent_app_type] => utility [patent_app_number] => 16/997197 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997197 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997197
EphA2 T-cell epitope agonists and uses therefore Aug 18, 2020 Issued
Array ( [id] => 18209482 [patent_doc_number] => 20230055742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => Strain of Beijerinckia Fluminensis and Application Thereof in Arsenic Oxidation [patent_app_type] => utility [patent_app_number] => 17/790406 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2850 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790406 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/790406
Strain of Beijerinckia Fluminensis and Application Thereof in Arsenic Oxidation Aug 9, 2020 Abandoned
Array ( [id] => 16437405 [patent_doc_number] => 20200354731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => ENDOPLASMIC RETICULUM TARGETING SIGNAL [patent_app_type] => utility [patent_app_number] => 16/940440 [patent_app_country] => US [patent_app_date] => 2020-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/940440
ENDOPLASMIC RETICULUM TARGETING SIGNAL Jul 27, 2020 Abandoned
Array ( [id] => 16435801 [patent_doc_number] => 20200353126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => Sterilization Process [patent_app_type] => utility [patent_app_number] => 16/940431 [patent_app_country] => US [patent_app_date] => 2020-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940431 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/940431
Sterilization process Jul 27, 2020 Issued
Menu